🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how well daratumumab, ixazomib, and dexamethaso...
Status
Unknown
Location
Emory University Hospital/Winship Cancer Institute
Start Date
2019-07-03
Trial ID
NCT03942224
Treatments Being Tested
This is an open label trial of Anti PD1/MD-3475, Pomalidomide and dexametha...
Status
Terminated
Location
Greenebaum Cancer Center at University of Maryland Medical Center
Start Date
2014-12-30
Trial ID
NCT02289222
Treatments Being Tested
To increase the conversion rate from MRD-positive to MRD-negative CR in pat...
Status
Recruiting
Location
MD Anderson Cancer Center
Start Date
2022-12-01
Trial ID
NCT05091372
Treatments Being Tested
The purpose of this expanded access treatment protocol is to provide patien...
Status
Approved For Marketing
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT05463939
Treatments Being Tested
Lenalidomide maintenance therapy following autologous stem cell transplant ...
Status
Active Not Recruiting
Location
University of Nebraska Medical Center
Start Date
2022-06-14
Trial ID
NCT05177536
Treatments Being Tested
To explore the efficacy and safety of pomalidomide and bendamustine with de...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2021-02
Trial ID
NCT04762745
This is a Phase I open-label, multicenter study designed to evaluate the sa...
Status
Terminated
Location
Colorado Blood Cancer Institute (CBCI) at Presbyterian/ St. Luke's Medical Center
Start Date
2019-07-22
Trial ID
NCT04045028
Treatments Being Tested
Observational clinical trial recruiting Smouldering Myeloma patients (SMM) ...
Status
Unknown
Location
University College London Hospitals
Start Date
2021-04-15
Trial ID
NCT05047107
Treatments Being Tested
The purpose of this study is to identify the recommended Phase 2 dose(s) (R...
Status
Active Not Recruiting
Location
City of Hope
Start Date
2017-05-16
Trial ID
NCT03145181
Treatments Being Tested
This protocol will enroll subjects with advanced hematologic malignancies w...
Status
Completed
Location
University of Pennsylvania
Start Date
2009-01
Trial ID
NCT00891592
Treatments Being Tested